Such as olaparib significantly reduces the protein expression of STAT‐6 and GATA‐3, inhibits the inflammasome signaling, and reduces the remodeling characteristics associated with chronic asthma in mice.32 This evidence concerns the gene GATA3 and chronic asthma.